recall
saveAmgen, Inc. recall (Cls II)
community read0 votes
Neupogen (filgrastim) For Injection, 480 mcg/1.6 mL (300 mcg/1 mL), 1.6 mL single Dose Vial, Rx Only, For Subcutaneous or Intravenous Use Only, Sterile Solution - No Preservative, Amgen Inc. Thousand Oaks, CA 91320, NDC 55513-546-01 (vial), NDC 55513-546-10 (box). — Reason: Stability data does not support expiry: the products have the potential to be out of specification at the time of expiry of 36-months. — Status: Ongoing
view source ↗Data sources
last refreshed 20m ago
Found something off?
same company · ±60 days · 6
- recallAmgen, Inc. recall (Cls II)Mar 26, 2025
- approvalAMJEVITA: AMJEVITA (ADALIMUMAB-ATTO) — FDA approvalApr 7, 2025
- approvaleculizumab biosimilar: BKEMV (ECULIZUMAB-AEEB) — FDA approvalApr 18, 2025
- approvalblinatumomab: BLINCYTO (BLINATUMOMAB) — FDA approvalApr 29, 2025
- approvaleculizumab biosimilar: BKEMV (ECULIZUMAB-AEEB) — FDA approvalJan 30, 2025
- approvalAMJEVITA: AMJEVITA (ADALIMUMAB-ATTO) — FDA approvalMay 20, 2025
🐶 often sniffed alongside
top 8- tagApproval84 co-mentions · 42 sources
- drugOTEZLA28 co-mentions · 14 sources
- drugAMJEVITA26 co-mentions · 13 sources
- drugapremilast14 co-mentions · 14 sources
- drugBKEMV14 co-mentions · 7 sources
- drugapremilast ER14 co-mentions · 14 sources
- tagSmall Molecule14 co-mentions · 14 sources
- drugHUMIRA13 co-mentions · 13 sources
comments(0)
5-min edit window · permanent after that